|
|
Article: Biocontrol Subsidiary, IDT, Receives FDA Marketing Clearance For ThermoChem-HT System(TM).
- Article from:
- PR Newswire
- Article date:
- January 12, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PITTSBURGH, Jan. 12 /PRNewswire/ -- Biocontrol Technology, Inc. (OTC Bulletin Board: BICO) subsidiary, IDT, Inc., in conjunction with HemoCleanse, Inc., announced today that they have received FDA clearance to market the ThermoChem-HT System(TM) and related disposables.
The ThermoChem-HT System and disposables will now be available to hospitals and doctors nationwide to help standardize a revolutionary cancer treatment. This treatment has been developed clinically at Wake Forest University Baptist Medical Center since 1991 by Dr. Brian Loggie, a surgical oncologist, with correlative laboratory studies performed by Ronald Fleming, Pharm. D., an adjunct professor. ...